Skip to main content
Premium Trial:

Request an Annual Quote

Quebec Ready to Plant Flag in Genomics Field

Premium

After spending more than 20 years in the pharmaceutical industry — including the last 15 doing business development in Canada for GlaxoSmithKline — Paul L’Archevêque has the connections he’ll need in his new role as president and CEO of Génome Québec. A nonprofit organization, Génome Québec aims to promote the genomics industry in Quebec by building a genomics center in Montreal and financially supporting research at universities in the region.

L’Archevêque, 49, says his extensive work in pharma was “probably how I ended up becoming more knowledgeable about this initiative and getting more interested in it.” Originally a science student at the University of Montreal, he feels he fits into the genomics industry already.

Founded in late 2000, Génome Québec receives about half of its funding from Genome Canada, another nonprofit organization with which it works closely but is not affiliated, and also gets a significant amount from the Quebec government. L’Archevêque’s goal is to “ensure the sustainability of this initiative over the long run,” and he expects that a good chunk of future funding will come from private investors who are attracted by the particular genomics projects underway.

“We believe we have strong researchers,” he says. “We’re trying to create in our own environment here in Quebec a capability around genomics which is of international stature.”

— Meredith Salisbury

 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.